Wegovy Lawsuit: The Claims, the MDL, the Status
Wegovy lawsuit: what happened, what it means for patients, and where to read the record.
- Active ingredient
- semaglutide
- Manufacturer
- Novo Nordisk
- How it is taken
- Weekly injection or daily pill
- FDA-approved for
- Weight loss, Heart risk, MASH liver disease
At a glance: Wegovy
Its half-life is about 1 week. After 7 d, half is gone, and about 3% remains after five half-lives (35 d).
In STEP 1 over 68 weeks, weight loss was 14.9% of body weight, compared with 2.4% on placebo.
Monthly prices in US dollars cover both the list price and self-pay offers. Each comes from the maker's price page.
Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.